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a  b  s  t  r  a  c  t
Aims:  Impaired  left ventricular  (LV) strain  is  associated  with  an  increased  risk  of  cardiac  events  in asymp-
tomatic  severe  aortic  stenosis  (AS).  We  aimed  to  evaluate  the  prognostic  value  of  global  LV  strain  in
conservatively  treated  patients  with  symptomatic  AS.
Methods and results:  This  cohort  study  retrospectively  reviewed  symptomatic  AS patients  who  were
treated  conservatively  or surgically  between  July  2007  and  April  2010.  We  measured  their  global longi-
tudinal  strain  (GLS)  and  global  circumferential  strain  (GCS).  Clinical  events  were  deﬁned  as  readmission
for  heart  failure  or all-cause  death  for 2  years.  GLS  and GCS  could  predict  a  worse  outcome  in the
conservatively  treated  group  at cut-offs  of =−16.5%  (77%  sensitivity  and  67%  speciﬁcity)  and  =−22.2%
(92%  sensitivity  and  83%  speciﬁcity),  respectively.  By  univariate  Cox regression  analysis,  age,  logisticpeckle tracking
train
EuroSCORE,  aortic  valve  area,  GLS,  and  GCS  were  signiﬁcant  predictors.  When  adjusted  for  age,  logistic
EuroSCORE,  and  aortic  valve  area,  impaired  GLS  and  GCS  were  independently  associated  with  a higher
risk  of  clinical  events.
Conclusion: In conservatively  treated  patients  with  symptomatic  AS,  impaired  GLS and  GCS were asso-
ciated  with an  increased  risk  of  cardiac  events  during  a 2-year  follow-up.  Global  LV  strain  may  help  to
deﬁne  a higher  risk subset;  therefore,  a larger  and  prospective  observation  study  would  be  necessary.
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Previous studies have demonstrated that patients with severe
ortic stenosis (AS) and a preserved left ventricular (LV) ejec-
ion fraction have impaired global longitudinal strain (GLS), and
hat the impairment of GLS improves after aortic valve replace-
ent [1–5]. In patients with asymptomatic severe AS, impaired
LS was reported to be associated with a poor prognosis [6]. Clin-
cally, up to 30% of patients with symptomatic AS are treated
onservatively [7–9]. The role of strain parameters in the prog-
osis of symptomatic AS patients who are treated conservatively
emains unclear. Accordingly, the aims of this study were to assess
lobal LV strain in patients with symptomatic AS and a pre-
erved LV ejection fraction who were treated conservatively, and
o evaluate the prognostic value of strain parameters in these
atients.
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Methods
Patients
This cohort study retrospectively reviewed symptomatic AS
patients who were treated conservatively or surgically between
July 2007 and April 2010. Patients were excluded from the anal-
ysis if they were not in sinus rhythm or had a LV ejection fraction
<50%. Patients with a previous valve replacement, severe aortic
or mitral regurgitation, and unsuitable two-dimensional imaging
quality for speckle-tracking analysis were also excluded from the
study. Patients were included after their ﬁrst symptomatic presen-
tation of angina, dyspnea, or both. Patients who did not undergo
aortic valve replacement were conservatively treated patients [10].
The predominant reasons included high estimated surgical risk
and patient refusal. If patients were not managed surgically, med-
ications including aspirin (35%), statin (19%), beta-blocker (26%),
and renin–angiotensin system blocker (48%) were given. The study
group consisted of 31 conservatively treated patients who  met
these criteria; these patients were divided into 2 subgroups accord-
ing to the occurrence of clinical events (patients with or without
clinical events within 2 years). The clinical events were deﬁned
as all-cause death or readmission for heart failure, which were
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etermined by evaluation of medical records. Additionally, we
nrolled a control (surgical) group of 31 patients who met  the above
riteria but were treated with aortic valve replacement for the com-
arison of clinical outcome with the conservatively treated group.
ll echocardiographic measurements were performed by an expe-
ienced research personnel blinded to other clinical characteristics.
The study complies with the Declaration of Helsinki. The
esearch protocol was approved by the local Institutional Review
oard.
chocardiography
Conventional 2-dimensional echocardiography was performed
sing commercially available equipment (Vivid 7, GE, Horten,
orway) with a 3.5-MHz transducer. LV ejection fraction was
etermined by the biplane Simpson’s method. LV mass was cal-
ulated using the formula proposed by Devereux et al. [11], and
as corrected by body surface area to derive the LV mass index.
easurements of LV diastolic ﬁlling included the mitral early (E)-
elocity, mitral late (A)-velocity, and the E/A ratio [10]. In addition,
issue Doppler echocardiography was performed with the peak
arly diastolic velocity (E′) measured at the basal septal segment
n the apical 4-chamber view and the E/E′ ratio was calculated [12].
he maximum transaortic pressure gradient was calculated using
he Bernoulli equation, and mean transaortic pressure gradient was
alculated by averaging the instantaneous gradients over the ejec-
ion period on the continuous-wave Doppler recordings [13]. The
ortic valve area (AVA) was calculated with the continuity equation
s previously described [14–17].
train analysis
Two-dimensional speckle-tracking strain analysis was per-
ormed ofﬂine by using a commercially available program
EchoPAC version 110.0, GE) [18–20]. The frame rate for this study
as between 50 and 80 Hz. Longitudinal strain was obtained from
he apical 4-chamber, 2-chamber, and long-axis views in an 18-
egment LV model [21,22]. Circumferential strain was  calculated
rom the parasternal short-axis view in the basal-, mid-, and apical-
V levels. If 2 or more segments were inadequately tracked, we
xcluded the data because the images were not useable for speckle-
racking analysis [19]. Three patients (2 conservatively treated; 1
urgically treated) were excluded from the analysis due to inade-
uate imaging quality. Subsequently, peak longitudinal strain and
able 1
aseline characteristics.
Total (n = 62) Conse
Age (years) 70.2 ± 12.4 72.9 
Male,  n (%) 30 (48) 15 (4
Hypertension, n (%) 35 (56) 16 (5
Dyslipidemia,  n (%) 13 (21) 4 (1
Smoking,  n (%) 8 (13) 4 (1
Diabetes  mellitus, n (%) 16 (26) 10 (3
Coronary  artery disease, n (%) 12 (19) 5 (1
Logistic  EuroSCORE 10.4 ± 10.7 14.3 
LV  ejection fraction (%) 72.1 ± 9.1 71.4 
LV  mass index (g/m2) 172.9 ± 67.9 171.6 
Maximal  PG (mmHg) 66.8 ± 23.9 56.1 
Mean  PG (mmHg) 39.3 ± 18.2 32.5 
E/A  0.88 ± 0.23 0.99
E/E′ 20.3 ± 7.0 21.7 
Aortic  valve area (cm2) 0.88 ± 0.23 0.95
Death  12 (19) 9 (2
Readmission  for heart failure 4 (11) 4 (1
VR, aortic valve replacement; E/A, the ratio between early diastolic mitral inﬂow velocity
arly  diastolic tissue velocity; LV, left ventricular; PG, pressure gradient.ology 62 (2013) 301–306
peak circumferential strain of all 18 LV segments were averaged to
assess the GLS and global circumferential strain (GCS).
Statistical analysis
Data  are presented as mean ± standard deviation or as a count
(percentage). Statistical analyses were performed using the Statis-
tical Package for Social Sciences (SPSS) statistical software, version
18 for Windows. To compare each parameter between the groups,
the chi-square test and Fisher’s exact test were used for cat-
egorical variables, as appropriate, and the 2-sample t test and
Mann–Whitney U-test were used for continuous variables. A Cox
proportional hazards model was used for multivariate analysis
to investigate which prognostic factors identiﬁed using univari-
ate analysis were signiﬁcantly associated with clinical events.
Receiver operating characteristic curve (ROC) analysis was  used
to determine the optimal cut-off value of strain parameters for
the prediction of clinical events. Event-free survival between the
groups and subgroups was  compared using a log-rank test, and rep-
resentative Kaplan–Meier survival curves were constructed. The
effect of different variables on event-free survival was investigated
using the Cox proportional hazard model. For all analyses, a p-value
<0.05 was  considered statistically signiﬁcant.
Results
Baseline characteristics
Baseline characteristics for the study patients are shown in
Table 1. The mean age was 70.2 ± 12.4 years and approximately half
of the patients were male. No signiﬁcant differences were found
in age, gender, risk factors of coronary artery disease, percent-
age of coronary artery disease, LV mass, and LV ejection fraction
between the conservatively treated group and the surgical con-
trol group. There were signiﬁcant differences in logistic EuroSCORE,
maximal transaortic pressure gradient, mean transaortic pressure
gradient, and AVA between the 2 groups. In the conserva-
tively treated group, the GLS and GLS rate were −16.1 ± 3.2%
and −0.86 ± 0.20 s−1, respectively; the GCS and GCS rate were
−22.7 ± 5.2% and −1.32 ± 0.38 s−1, respectively.Clinical  events and event-free survival
Four patients (6%) were admitted for heart failure and 12
patients (19%) died during the follow-up period. The cause of death
rvatively treated (n = 31) AVR (n = 31) p-Value
± 14.5 67.4 ± 9.2 0.08
8) 15 (48) 1.00
2) 19 (61) 0.44
3) 9 (29) 0.12
3) 4 (13) 1.00
2) 6 (19) 0.25
6) 7 (23) 0.52
± 12.1 6.5 ± 7.5 0.003
± 8.7 72.8 ± 9.7 0.53
± 66.1 174.2 ± 71.0 0.89
± 20.6 77.4 ± 22.3 0.001
± 13.5 53.5 ± 18.7 0.001
 ± 0.53 0.86 ± 0.39 0.29
± 7.6 18.8 ± 6.1 0.11
 ± 0.21 0.81 ± 0.23 0.01
9) 3 (10) 0.12
3) 0 (0) 0.32
 and late inﬂow velocity; E/E′ , the ratio between early diastolic inﬂow velocity and
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Table  2
Comparisons between conservatively treated patients with and without clinical
events.
Events (n = 13) No event (n = 18) p-Value
Age (years) 81.6  ± 5.2 66.7  ± 16.0 0.01
Male,  n (%) 17 (55) 14 (45) 0.61
Hypertension, n (%) 9 (69) 7 (39) 0.10
Dyslipidemia, n (%) 1 (8) 3 (17) 0.62
Smoking, n (%) 3 (23) 1 (6) 0.28
Diabetes mellitus, n (%) 6 (46) 4 (22) 0.25
Coronary artery disease, n (%) 4 (31) 1 (6) 0.13
Logistic EuroSCORE 19.6 ± 11.6 10.4  ± 11.1 0.04
LV  ejection fraction (%) 68.0 ± 8.9 73.5 ± 8.1 0.17
Stroke volume (ml) 70.8 ± 26.8 72.5 ± 18.8 0.39
Relative wall thickness (mm)  0.6 ± 0.1 0.6 ± 0.1 0.93
LV mass index (g/m2) 205.8 ± 73.6 147.0 ± 48.5 0.08
Maximal PG (mmHg) 63.6 ± 23.1 50.7 ± 17.3 0.10
Mean PG (mmHg) 38.0 ± 14.2 28.4 ± 11.8 0.03
Aortic valve area (cm2) 0.9 ± 0.2 1.0 ± 0.2 0.009
E/A 1.08 ± 0.75 0.92 ± 0.29 0.79
E/E′ 23.7 ± 7.6 20.2  ± 7.5 0.11
E/A, the ratio between early diastolic mitral inﬂow velocity and late inﬂow veloc-



















Comparisons of global left ventricular strain between AVR group and patients
with/without  events in the conservatively treated group.
AVR group Conservatively treated group
Events (n = 13) No event (n = 18)
GLS (%) −15.2 ± 3.8 −13.7 ± 3.8 −17.8 ± 2.0*,#
GCS (%) −20.3 ± 5.7 −19.2 ± 4.9 −25.4 ± 4.0*,#
AVR, aortic valve replacement; GCS, global circumferential strain; GLS, global lon-
gitudinal strain.
* p < 0.05 events vs. no events in the conservatively treated patients.
F
s
(elocity;  LV, left ventricular; PG, pressure gradient.
as noncardiac in 2 (1 gastrointestinal bleeding, 1 septic shock).
he 10 cardiac deaths were due to congestive heart failure (5),
yocardial infarction (3), and sudden cardiac death (2). The clinical
vent rate over 2 years was signiﬁcantly greater in the conser-
atively treated group than in the surgical group (42% vs. 10%,
 = 0.008). In the conservatively treated group, there were signif-
cant differences in age, logistic EuroSCORE, LV mass index, mean
ransaortic pressure gradient, AVA, GLS, and GCS between patients
ith and without clinical events (Tables 2 and 3). In the surgical
roup, there were no signiﬁcant differences in those baseline char-
cteristics and LV strain between patients with and without events.
here were signiﬁcant differences in GCS and GLS between the aor-
ic valve replacement group and patients without events in the
onservatively treated group, but no signiﬁcant differences in GCS
nd GLS between the aortic valve replacement group and patients
ith events in the conservatively treated group (Table 3). In the ROC
ig. 1. Receiver operating characteristic (ROC) curve analysis for the prediction of 2-year c
train (GCS), and combination of GLS and GCS and (B) age, logistic EuroScore, mean pres
AVA).# p < 0.05, AVR group vs. no events in the conservatively treated patients.
curve analysis for the prediction of 2-year clinical events, several
indices including age, logistic EuroScore, mean pressure gradient,
stroke volume, ejection fraction, AVA, GLS, GCS, and combined GLS
and GCS were analyzed. Among these prognostic factors, GCS or GLS
were the most valuable factors for the patients with symptomatic
AS who were treated conservatively (Fig. 1). Both GLS and GCS had
an area under the curve (AUC) that was greater than the line of no
information (AUC = 0.838, p = 0.002 for GLS; AUC = 0.865, p = 0.001
for GCS). Of note, GLS and GCS could differentiate between patients
with or without clinical events in the conservatively treated
group (cut-off value = −16.5% for GLS, 76.9% sensitivity, 66.7%
speciﬁcity; cut-off value = −22.2% for GCS, 92.3% sensitivity, 83.3%
speciﬁcity).
The conservatively treated patients had a worse outcome com-
pared with the surgical group [hazard ratio (HR): 2.31, 95%
conﬁdence interval (CI): 1.23–4.33]. In the conservatively treated
patients, the event-free survival was worse in patients with
impaired LV strain than in those with relatively preserved LV strain
(HR: 4.67, 95% CI: 1.27–17.09 for GLS ≥ −16.5% vs. GLS < −16.5%;
HR: 22.03, 95% CI: 2.84–170.99 for GCS ≥ −22.2% vs. GCS < −22.2%;
Fig. 2). There was  no signiﬁcant difference in event-free survival
between the surgical group and the conservatively treated patients
with preserved LV strain. By using the Cox regression analysis to
predict the event-free survival, age, logistic EuroSCORE, AVA, GLS,
and GCS were signiﬁcant predictors according to the univariate
analysis (Table 4). When adjusted for age, logistic EuroSCORE, and
linical events including: (A) global longitudinal strain (GLS), global circumferential
sure gradient (PG), stroke volume (SV), ejection fraction (EF), and aortic valve area

























dig. 2. Kaplan–Meyer analysis for event-free survival in patients with symptomatic
GLS)  or impaired global circumferential strain (GCS) had a worse outcome than pa
VA, impaired GLS and GCS were independently associated with a
igher risk of clinical events over 2 years.
iscussion
We demonstrated the value of global LV strain in the prediction
f outcome for symptomatic AS patients who had to be treated
urgically but conservatively. Importantly, not all symptomatic AS
atients without AVR had poor prognosis, but the outcome of
onservatively treated patients with preserved LV strain was not
nferior to those with aortic valve replacement. Among the echocar-
iographic variables that were evaluated, only GLS and GCS were
ndependent predictors for 2-year clinical events in conservatively
reated patients with symptomatic AS.
Previous studies have shown that impaired GLS is associated
ith abnormal exercise response and an increased risk of cardiac
vents in patients with asymptomatic severe AS [23,24]. In the
resent study, not only GLS but also GCS could predict clinical out-
ome in symptomatic AS patients who were treated conservatively.
n patients with severe AS, LV hypertrophy and the small effec-
ive oriﬁce of the aortic valve impair coronary ﬂow reserve, which
enders the myocardium susceptible to ischemic injury, espe-
ially in the subendocardium [25–28]. The subendocardium mainly
able 4
ox-regression hazard ratio in univariate and multivariate analyses for predicting cardiac
Univariate analysis 
HR p-Value 
Age (years) 1.13 0.01 
Logistic  EuroSCORE 1.05 0.02 
LV  ejection fraction (%) 0.95 0.11
Maximal pressure gradient (mmHg) 1.02 0.14
Mean pressure gradient (mmHg) 1.03 0.08
Aortic valve area (cm2) 0.04 0.02 
E/A  1.60 0.36
E/E′ 1.04 0.16
Global longitudinal strain (%) 1.35 <0.001 
Global  circumferential strain (%) 1.24 0.001 
I, conﬁdence interval; E/A, the ratio between early diastolic mitral inﬂow velocity and l
iastolic tissue velocity; HR, hazard ratio; LV, left ventricular.c stenosis. Conservatively treated patients with impaired global longitudinal strain
 with preserved strain or patients who underwent aortic valve replacement (AVR).
consists  of longitudinal ﬁbers; thus, longitudinal shortening is the
ﬁrst measurement to decrease in patients with AS [23,24,29,30].
Circumferential shortening is initially increased to compensate for
the decrease in longitudinal shortening and to maintain normal
LV ejection [4,31]. Hence, a decrease in circumferential shortening
reﬂects more extensive myocardial injury and the loss of LV com-
pensation [31–33]. This may  explain the ﬁndings in the present
study indicating that GLS and GCS are signiﬁcant prognostic factors
in symptomatic AS patients.
Symptomatic severe AS is an indication for aortic valve replace-
ment [34]. However, some patients are denied intervention due
to perceived high operative risk, their symptoms being regarded
as mild stenosis, or patient preference [7–9]. Since the long-term
outcome after aortic valve replacement is worse when the LV ejec-
tion fraction is impaired [35,36], it is imperative that patients are
referred for intervention before the LV ejection fraction is reduced.
Previous studies have shown that LV strain analysis could provide
a better characterization of subtle LV dysfunction than the LV
ejection fraction [17,18,37]. The present study demonstrated that
GLS and GCS were useful in risk stratiﬁcation of symptomatic AS
patients who had a preserved ejection fraction and were treated
conservatively, and could identify patients with poor outcome.
Additionally, the recent development of transcatheter aortic valve
 events in conservatively treated patients.
Multivariate analysis (model 1) Multivariate analysis (model 2)
HR (95% CI) p-Value HR (95% CI) p-Value
1.14 (0.99–1.30) 0.05 1.29 (1.07–1.57) 0.009
1.02 (0.96–1.08) 0.62 1.02 (0.96–1.08) 0.62
0.41 (0.02–8.36) 0.56 0.16 (0.004–6.77) 0.33
1.30 (1.06–1.58) 0.01
1.28 (1.10–1.49) 0.001
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eplacement treatment offers an effective treatment for symp-
omatic severe AS patients who decline surgery due to high surgical
isk for aortic valve replacement [38].
Apart from the intrinsic limitations associated with a ret-
ospective study, the other limitations were this work being a
ingle-center study, a small sample size, and a heterogeneous study
opulation that included patients with coronary artery disease and
ypertension. However, coronary artery disease and hypertension
re frequently associated co-morbidities in patients with symp-
omatic AS, and the exclusion of these conditions may  mask the
linical spectrum of the disease. The inclusion of these patients
ields a realistic view of what is observed in daily clinical practice.
ore severe AS was demonstrated in the surgical group com-
ared to the conservatively treated group in our study population.
hat could be explained by the fact that the severity of AS could
ffect our treatment strategy for AS patients although they were
ll symptomatic. However, the therapeutic decision-making should
e based on whether clinical symptoms were present [34]. We  had
aken the AS severity into account and found that it was not an
ndependent predictor of clinical events. A recent study indicated
hat aging results in a decrease in GLS [39]. The present study also
emonstrated that age was an independent predictor of clinical
vents. As our study population mostly comprised elderly patients,
dditional studies evaluating a younger population could provide
ore speciﬁc information in this regard. Our study also demon-
trated a real-world elderly patient population with symptomatic
evere AS not undergoing aortic valve replacement due to age (i.e.
ife expectancy) and comorbidities. The observed high surgical risk
logistic EuroScore 19%) was similar to that of the patients hav-
ng transcatheter aortic valve replacement [40]. Global LV strain
ay help identify these high-risk patients who were treated con-
ervatively as potential candidates for transcatheter aortic valve
eplacement.
In conclusion, speckle-tracking strain analysis could detect
yocardial deformation abnormalities and is useful for the predic-
ion of clinical outcome in symptomatic AS patients who are treated
onservatively. The outcome of conservatively treated patients
ith preserved LV strain was not inferior to those with aortic valve
eplacement. Global LV strain may  help to deﬁne a higher risk sub-
et; therefore, a larger and prospective observational study would
e necessary.
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